Literature DB >> 21945070

Type I and III collagen degradation products in serum predict patient survival in head and neck squamous cell carcinoma.

Sini Nurmenniemi1, Marja-Kaisa Koivula, Pia Nyberg, Taina Tervahartiala, Timo Sorsa, Petri S Mattila, Tuula Salo, Juha Risteli.   

Abstract

Cancer invasion induces extracellular matrix remodeling and collagen degradation. The aim of this study was to assess whether serum levels of type I and III collagen degradation products were associated with patient survival in head and neck squamous cell carcinoma (HNSCC). A novel enzyme immunoassay was developed for measuring type III collagen N-terminal telopeptide (IIINTP) in human serum samples. In addition, type I collagen C-terminal telopeptide (ICTP), matrix metalloprotease-8 (MMP-8) and tissue inhibitor of metalloproteases-1 (TIMP-1) were assessed in 205 blood samples from HNSCC patients. High levels of serum ICTP and IIINTP and plasma TIMP-1 were associated with poor survival. The concentration of ICTP was associated with levels of IIINTP and TIMP-1. The plasma concentration of MMP-8 was associated with tumor stage, but not with survival or levels of ICTP, IIINTP or TIMP-1 suggesting that other collagenases/proteases are responsible for the cleavage of type I and type III collagens. The rate of type I and type III collagen degradation is associated with patient survival and can be used as a prognostic marker in HNSCC.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21945070     DOI: 10.1016/j.oraloncology.2011.09.002

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  12 in total

1.  Application of "Tissueoid Cell Culture System" Using a Silicate Fiber Scaffold for Cancer Research.

Authors:  Shoko Murakami; Ken-Ichi Mukaisho; Takuya Iwasa; Masaaki Kawabe; Saori Yoshida; Naoko Taniura; Takahisa Nakayama; Masaharu Noi; Gaku Yamamoto; Hiroyuki Sugihara
Journal:  Pathobiology       Date:  2020-09-23       Impact factor: 4.342

2.  Prognostic value of type XXII and XXIV collagen mRNA expression in head and neck cancer patients.

Authors:  Kiyoshi Misawa; Takeharu Kanazawa; Atsushi Imai; Shiori Endo; Daiki Mochizuki; Hirofumi Fukushima; Yuki Misawa; Hiroyuki Mineta
Journal:  Mol Clin Oncol       Date:  2013-12-24

3.  Anti-heparanase aptamers as potential diagnostic and therapeutic agents for oral cancer.

Authors:  Suzanne C Simmons; Hannaleena Jämsä; Dilson Silva; Celia M Cortez; Edward A McKenzie; Carolina C Bitu; Sirpa Salo; Sini Nurmenniemi; Pia Nyberg; Juha Risteli; Carlos E B deAlmeida; Paul E C Brenchley; Tuula Salo; Sotiris Missailidis
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

4.  Serum biomarkers reflecting specific tumor tissue remodeling processes are valuable diagnostic tools for lung cancer.

Authors:  Nicholas Willumsen; Cecilie L Bager; Diana J Leeming; Victoria Smith; Claus Christiansen; Morten A Karsdal; David Dornan; Anne-Christine Bay-Jensen
Journal:  Cancer Med       Date:  2014-07-18       Impact factor: 4.452

5.  The interplay of matrix metalloproteinase-8, transforming growth factor-β1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma.

Authors:  Pirjo Åström; Krista Juurikka; Elin S Hadler-Olsen; Gunbjørg Svineng; Nilva K Cervigne; Ricardo D Coletta; Juha Risteli; Joonas H Kauppila; Sini Skarp; Samuel Kuttner; Ana Oteiza; Meeri Sutinen; Tuula Salo
Journal:  Br J Cancer       Date:  2017-08-03       Impact factor: 7.640

Review 6.  Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology.

Authors:  Neel I Nissen; Morten Karsdal; Nicholas Willumsen
Journal:  J Exp Clin Cancer Res       Date:  2019-03-06

7.  The Role of MMP8 in Cancer: A Systematic Review.

Authors:  Krista Juurikka; Georgina S Butler; Tuula Salo; Pia Nyberg; Pirjo Åström
Journal:  Int J Mol Sci       Date:  2019-09-11       Impact factor: 5.923

Review 8.  Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types.

Authors:  Nicholas Willumsen; Christina Jensen; George Green; Neel I Nissen; Jaclyn Neely; David M Nelson; Rasmus S Pedersen; Peder Frederiksen; Inna M Chen; Mogens K Boisen; Astrid Z Johansen; Daniel H Madsen; Inge Marie Svane; Allan Lipton; Kim Leitzel; Suhail M Ali; Janine T Erler; Daan P Hurkmans; Ron H J Mathijssen; Joachim Aerts; Mohammed Eslam; Jacob George; Claus Christiansen; Mina J Bissel; Morten A Karsdal
Journal:  Cell Mol Life Sci       Date:  2022-03-25       Impact factor: 9.207

9.  Extracellular matrix specific protein fingerprints measured in serum can separate pancreatic cancer patients from healthy controls.

Authors:  Nicholas Willumsen; Cecilie L Bager; Diana J Leeming; Victoria Smith; Morten A Karsdal; David Dornan; Anne-Christine Bay-Jensen
Journal:  BMC Cancer       Date:  2013-11-21       Impact factor: 4.430

Review 10.  The role of collagen in cancer: from bench to bedside.

Authors:  Shuaishuai Xu; Huaxiang Xu; Wenquan Wang; Shuo Li; Hao Li; Tianjiao Li; Wuhu Zhang; Xianjun Yu; Liang Liu
Journal:  J Transl Med       Date:  2019-09-14       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.